ABSTRACTS Archives - Page 41 of 107

P26 Immunomagnetic enrichment of circulating tumor cells prior to tumor Ig specific qASO-PCR enhances the sensitivity of minimal residual disease detection in multiple myeloma

BJH - 2018, issue Abstract Book BHS, february 2018

W. De Brouwer MD, J. Van Der Straeten MSc, C. Demanet MD, PhD, H. Schots MD, PhD, M. Bakkus PhD, I. Van Riet PhD

P27 Role of FOXO1 mutations in the development of diffuse large B-cell lymphoma

BJH - 2018, issue Abstract Book BHS, february 2018

E. Bollaert , A. Velghe , G. Dachy , V. Havelange MD, PhD, J.B. Demoulin

P28 An immunocompetent patient with EBV-related plasmablastic lymphoma in the small pelvis: a case report

BJH - 2018, issue Abstract Book BHS, february 2018

C. Debergh MD, D. Dierickx MD, PhD

P29 Breast implants: a rare cause of anaplastic large T-cell lymphoma

BJH - 2018, issue Abstract Book BHS, february 2018

S. Bailly MD, Y. Breners , S. Amat , L. Maindiaux , F. Dall’Armellina , C. Galant , A. Camboni MD, PhD, M. Coyette , E. Van den Neste MD, PhD, M.C. Vekemans MD

P30 Severe pancytopenia as presenting feature in newly diagnosed multiple myeloma (NDMM): a rare presentation

BJH - 2018, issue Abstract Book BHS, february 2018

C. De Vriendt , S. Kennes MD, M. Hofmans MD, PhD, P. Vlummens MD

P31 Approach of an IgM monoclonal gammopathy: clinical relevance of the MYD88 L265P mutation

BJH - 2018, issue Abstract Book BHS, february 2018

M. Vercruyssen MD, N. Cilla , L. Ameye , M. Paesmans , A. De Wind MD, PhD, P. Heimann MD, PhD, N. Meuleman MD, PhD, D. Bron MD, PhD

P33 Use of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice: Results from the Belgian Ibrutinib Real-World Data (BiRD) Study

BJH - 2018, issue Abstract Book BHS, february 2018

A. Janssens MD, PhD, S. Snauwaert MD, PhD, R. Wapenaar , C. Van Bogaert , A. Smet , V. Seynhaeve